Gordagen Receives AUD$1.3 Million R&D Tax Incentive
August 24, 2016 08:30 ET
|
Gordagen Pharmaceuticals
Refund based on AUD$2.8 million in eligible R&D spending used to advance the Company’s development programs.Two nutraceutical products currently being prepared for US launch by end of 2016. ...
Gordagen Reports Top-line Results of US Human Research (Clinical) Study for Muscle Recovery Supplement
May 02, 2016 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, May 02, 2016 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, an Australian private company, today announced positive top-line results of an independent early-phase US clinical...
Gordagen Secures Winding-Up Order Against Felda Wellness Corporation
March 08, 2016 16:05 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, March 08, 2016 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals Pty. Ltd., a privately-held company commercializing evidence-based nutraceuticals and pharmaceuticals, has secured a...
Gordagen to Trial New Drug Delivery Technology From Monash University
February 23, 2016 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, Feb. 23, 2016 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, an Australian nutraceutical and pharmaceutical company, is pleased to announce a collaborative research agreement...
Gordagen Enters Collaboration Agreement With Japan’s Matsumoto
January 05, 2016 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, Jan. 05, 2016 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, today announced it has entered...
Gordagen Granted Patent for Delivery Technology
December 16, 2015 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, is pleased to announce its...
Gordagen Positions for Growth and Secures R&D Loan
November 24, 2015 08:30 ET
|
Gordagen Pharmaceuticals
Chairman Fred Nadjarian retires from Board to assume role as Scientific Advisor.
Secures R&D loan facility through Metamor Capital Partners.
Preparing for US market entry with first...
Gordagen Appoints NPI as Exclusive Distribution Partner
November 03, 2015 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, Nov. 3, 2015 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, a privately held Australian company commercializing tocotrienol-based nutraceuticals and pharmaceuticals, has appointed...
Gordagen Appoints Natural Alternatives International Inc. as US Manufacturing Partner
September 15, 2015 08:30 ET
|
Gordagen Pharmaceuticals
MELBOURNE, Australia, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Gordagen Pharmaceuticals, an Australian private company commercializing evidence-based nutraceuticals and pharmaceuticals based on...
Gordagen Confirms Bioavailability in Phase I Study for Evidence-Based Nutraceuticals
September 08, 2015 08:30 ET
|
Gordagen Pharmaceuticals
Primary endpoints of Phase I Single Ascending Dose pharmacokinetic study achieved
Bioavailability of Gordagen's MELT3TM formulation confirmed, with good plasma levels obtained
Dose...